2013-02-14 14:26:22 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to produce reports on a company's attractiveness to long-term investors.

Ilhavo, Portugal — SADIF Investment Analytics, announces a new summary due diligence report covering the following companies:

Report Summary for: BayWa AG is an average quality company with a negative outlook. BayWa AG has medium business growth and is run by passable management. The trend in BayWa AG fair value exchange rate against its closest rated-competitor, KTG Agrar AG, has been appreciating over the past 2 weeks. When compared to its closest competitor, BayWa AG shows less undervaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-BYW6

Report Summary for: Commerzbank AG is a below average quality company with

a neutral outlook. Commerzbank AG has weak business growth and is run by passable management. The trend in Commerzbank AG fair value exchange rate against its closest rated-competitor, Landesbank Berlin Holding AG, has been depreciating over the past 2 weeks. When compared to its closest competitor, Commerzbank AG shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-CBK

Report Summary for: Bilfinger SE is an above average quality company with a neutral outlook. Bilfinger SE has medium business growth and is run by efficient management. The trend in Bilfinger SE fair value exchange rate against its closest rated-competitor, GEA Group Aktiengesellschaft, has been depreciating over the past 2 weeks. When compared to its closest competitor, Bilfinger SE shows similar undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-GBF

Report Summary for: Marseille-Kliniken AG is a below average quality company with a neutral outlook. Marseille-Kliniken AG has medium business growth and is run by efficient management. The trend in Marseille-Kliniken AG fair value exchange rate against its closest rated-competitor, Eifelhoehen-Klinik AG, has been depreciating over the past 2 weeks. When compared to its closest competitor, Marseille-Kliniken AG shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-39-MKA


About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering twenty four different markets and over 18,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.